AVIR   $3.25  2.85% Market Closed After Close 3.25 0.0

Atea Pharmaceuticals Inc
Total Cash 502.21M
totalCashPerShare 5.949
EBITDA -123.65M
Total Debt 2.02M
quickRatio 18.867
currentRatio 19.023
Total Revenue
debtToEquity 0.425
Revenue/Share
ROA -0.13646
ROE -0.32628
grossProfits
freeCashflow -8.25M
operatingCashflow -121.49M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -216.53M
forwardPE -2.0
floatShares 64.54M
sharesOutstanding 84.42M
sharesShort 2.63M
sharesShortPriorMonth 2.70M
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.70%
Short Ratio help_outline 12.35%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 5.644
Price To Book help_outline 0.63
earningsQuarterlyGrowth
netIncomeToCommon -176.00M
trailingEps -2.10%
forwardEps -1.79%
enterpriseToEbitda 1.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.49 3Q 2024
institutionsCount 149
lastUpdated Nov. 7, 2024, 3:28 a.m.